Who Owns CLDWW?

CALIDI BIOTHERPUTICS WTS — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

14

Total Inst. Value

$311K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2024

Top 10 Institutional Holders(Q1 2024)

#FundValueShares
1Polar Asset Management Partners Inc.$119K2,165,086
2HIGHBRIDGE CAPITAL MANAGEMENT LLC$85K1,627,956
3683 Capital Management, LLC$31K600,000
4ARISTEIA CAPITAL, L.L.C.$27K494,400
5NOMURA HOLDINGS INC$24K467,818
6Shaolin Capital Management LLC$23K450,000
7Walleye Trading LLC$1K20,052
8CITADEL ADVISORS LLC$82515,873
9UBS Group AG$7133
10Walleye Capital LLC$136,469

Related Stocks

Frequently Asked Questions

How many institutional investors hold CLDWW?

As of Q1 2024, 14 institutional investors report holding CLDWW (CALIDI BIOTHERPUTICS WTS) in their 13F filings.

Which hedge fund owns the most CLDWW?

The largest institutional holder of CLDWW is Polar Asset Management Partners Inc. with $119K in shares.

Are institutions buying or selling CLDWW?

This quarter, 14 institutions opened new positions in CLDWW and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.